92 related articles for article (PubMed ID: 2866950)
1. Nonsomatostatin secretory peptide(s) derived from prosomatostatin's amino terminus in a rat medullary thyroid carcinoma cell line.
Aron DC; Roos BA
Endocrinology; 1986 Jan; 118(1):218-22. PubMed ID: 2866950
[TBL] [Abstract][Full Text] [Related]
2. Elaboration of nonsomatostatin peptides containing the amino-terminal portion of prosomatostatin in a somatostatin-secreting human medullary thyroid carcinoma cell line.
Aron DC; Mendelsohn G; Roos BA
J Clin Endocrinol Metab; 1986 Jun; 62(6):1237-42. PubMed ID: 2871041
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin 28(1-12) in a somatostatin-secreting human medullary thyroid carcinoma cell line.
Aron DC; Hosta LP; Vargo EB; Andrews PC; Roos BA
Peptides; 1987; 8(2):207-11. PubMed ID: 2884645
[TBL] [Abstract][Full Text] [Related]
4. E-domain peptide of rat proinsulin-like growth factor-II: validation of a radioimmunoassay and measurement in culture medium and rat serum.
Hylka VW; Kent SB; Straus DS
Endocrinology; 1987 May; 120(5):2050-8. PubMed ID: 3569124
[TBL] [Abstract][Full Text] [Related]
5. High plasma levels of immunoreactive somatostatin in transgenic mice expressing a metallothionein-somatostatin fusion gene.
Low MJ; Goodman RH; Brinster RL; Palmiter RD; Hammer RE; Habener JF
Trans Assoc Am Physicians; 1984; 97():205-9. PubMed ID: 6152571
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin production by a human medullary thyroid carcinoma cell line.
Gagel RF; Palmer WN; Leonhart K; Chan L; Leong SS
Endocrinology; 1986 Apr; 118(4):1643-51. PubMed ID: 2868883
[TBL] [Abstract][Full Text] [Related]
7. Identification of cellular prosomatostatin and nonsomatostatin peptides derived from its amino terminus.
Aron DC; Andrews PC; Dixon JE; Roos BA
Biochem Biophys Res Commun; 1984 Oct; 124(2):450-6. PubMed ID: 6149749
[TBL] [Abstract][Full Text] [Related]
8. Processing and secretion of prosomatostatin by the pig pancreas.
Holst JJ; Baldissera FG; Bersani M; Skak-Nielsen T; Seier-Poulsen S; Nielsen OV
Pancreas; 1988; 3(6):653-61. PubMed ID: 2906123
[TBL] [Abstract][Full Text] [Related]
9. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
[TBL] [Abstract][Full Text] [Related]
10. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
Birnbaum RS; Muszynski M; Roos BA
Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin-like immunoreactivity in transplantable medullary carcinoma of rat thyroid: partial chromatographic and biological characterization.
Berelowitz M; Cibelius M; Szabo M; Frohman LA; Epstein S; Bell NH
Endocrinology; 1980 Nov; 107(5):1418-24. PubMed ID: 6107240
[TBL] [Abstract][Full Text] [Related]
12. Processing of prosomatostatin.
Benoit R; Esch F; Bennett HP; Ling N; Ravazzola M; Orci L; Mufson EJ
Metabolism; 1990 Sep; 39(9 Suppl 2):22-5. PubMed ID: 1976214
[TBL] [Abstract][Full Text] [Related]
13. Molecular heterogeneity and biological activity of immunoreactive somatostatin in medullary carcinoma of the thyroid.
Saito S; Saito H; Matsumura M; Ishimaru K; Sano T
J Clin Endocrinol Metab; 1981 Dec; 53(6):1117-22. PubMed ID: 6117566
[TBL] [Abstract][Full Text] [Related]
14. A neuroendocrine peptide derived from the amino-terminal half of rat procalcitonin.
Burns DM; Birnbaum RS; Roos BA
Mol Endocrinol; 1989 Jan; 3(1):140-7. PubMed ID: 2915645
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids stimulate the production of preprocalcitonin-derived secretory peptides by a rat medullary thyroid carcinoma cell line.
Muszynski M; Birnbaum RS; Roos BA
J Biol Chem; 1983 Oct; 258(19):11678-83. PubMed ID: 6311819
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing factor immunoreactivity in the hypothalamus and cortex of the rat: in vivo and in vitro studies.
Leidy JW; Robbins RJ
Endocrinology; 1988 Apr; 122(4):1652-7. PubMed ID: 3126041
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-28 [1-12]-like peptides.
Benoit R; Bohlen P; Ling N; Esch F; Baird A; Ying SY; Wehrenberg WB; Guillemin R; Morrison JH; Bakhit C
Adv Exp Med Biol; 1985; 188():89-107. PubMed ID: 2863951
[TBL] [Abstract][Full Text] [Related]
18. Ectopic production of somatostatin-like immuno- and bioactivity by cultured human pulmonary small cell carcinoma.
Szabo M; Berelowitz M; Pettengill OS; Sorenson GD; Frohman LA
J Clin Endocrinol Metab; 1980 Nov; 51(5):978-87. PubMed ID: 6106652
[TBL] [Abstract][Full Text] [Related]
19. Characterization of substance P-like immunoreactivity and tachykinin-encoding mRNAs in rat medullary thyroid carcinoma cell lines.
Cremins JD; Michel J; Farah JM; Krause JE
J Neurochem; 1992 Mar; 58(3):817-25. PubMed ID: 1371148
[TBL] [Abstract][Full Text] [Related]
20. In vitro biosynthesis of fish islet preprosomatostatin: evidence of processing and segregation of a high molecular weight precursor.
Shields D
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4074-8. PubMed ID: 6107904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
